molecular mechanisms of vascular thrombosis
血管血栓形成的分子机制
基本信息
- 批准号:07557058
- 负责人:
- 金额:$ 8.58万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (A)
- 财政年份:1995
- 资助国家:日本
- 起止时间:1995 至 1997
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
We have recently shown that chronic inhibition of nitric oxide (NO) synthesis by Nomega-nitro-L-arginine methyl ester (L-NAME) activates local angiotensin-converting enzyme (ACE) activity as well as induces vascular fibrosis and inflammatory changes in rats. Angiotensin II is known to activate coagulation cascade and inhibit fibrinolytic activity in the vessel wall.In the present study, we hypothesized that cyclic flow variations (CFV) , resulting from recurrent arterial thrombosis and its dislodgement, is induced in stenosed carotid arteries in a rat model of chronic inhibition of NO synthesis. Four groups of rats were studies : control group, L group received L-NAME,L+Hyd group received L-NAME and hydralazine, and L+A group received L-NAME and ACE inhibitor imidapril for 4 weeks. After anesthesia, stenosis was induced by constricting an exposed carotid artery, and CFV was determined using a ultrasonic flow prove. CFV provocation rate was 0% in the control group, 94% in the L group, 80% in the L+Hyd group, and 0% in the L+ACE inhibitor group. The carotid artery ACE activity was increased in the L and L+Hyd groups, and was suppressed in the L=ACE inhibitor group. In separate studies, treatment with thrombin antagonist argatroban, but not with vehicle or aspirin, nearly abolished CFV.There was no significant difference among groups in blood platelet count, platelet aggregation in response to collagen and indices of coagulation cascade (PT and APTT) .In conclusion, these findings suggest that CFV could be provoked by producing stenosis possibly via local thrombin generation in this animal model and that local ACE is likely to contribute to such changes.
我们最近发现,长期抑制一氧化氮(NO)合成的N-硝基-L-精氨酸甲酯(L-NAME)激活局部血管紧张素转换酶(ACE)的活性,以及诱导大鼠血管纤维化和炎症变化。血管紧张素II是已知的激活凝血级联反应和抑制纤溶活性在vessel wall.In目前的研究中,我们假设,循环流量的变化(CFV),导致反复动脉血栓形成和它的移位,在狭窄的大鼠模型的NO合成的慢性抑制颈动脉。实验分为4组:对照组、L组、L+Hyd组、L+A组,每组10只。麻醉后,通过缩窄暴露的颈动脉来诱导狭窄,并使用超声流量计测定CFV。CFV激发率在对照组为0%,L组为94%,L+Hyd组为80%,L+ACE抑制剂组为0%。L和L+Hyd组颈动脉ACE活性升高,L=ACE抑制剂组则被抑制。在单独的研究中,凝血酶拮抗剂阿加曲班治疗几乎消除了CFV,而赋形剂或阿司匹林治疗则没有。血小板计数、血小板对胶原蛋白的反应性聚集和凝血级联反应指数在组间无显著差异(PT和APTT)。总之,这些发现表明,CFV可能是通过在该动物模型中产生局部凝血酶而产生狭窄引起的,可能会促成这种变化。
项目成果
期刊论文数量(8)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Takemoto M et al.: "Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide systhesis in rats." J Clin Invest. 99. 278-287 (19
Takemoto M 等人:“组织血管紧张素转换酶活性在长期阻断一氧化氮合成引起的大鼠冠状血管和心肌结构变化的发病机制中发挥重要作用。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takemoto M et al.: "Chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blokade. Effects on cardiovascular remodeling in rats induced by the long-term blockade of nitric oxide synthesis." Hypertension. 30. 1621-1627 (1997)
Takemoto M 等人:“慢性血管紧张素转换酶抑制和血管紧张素 II 1 型受体阻断。长期阻断一氧化氮合成对大鼠心血管重塑的影响。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ito A.et al: "Chronic inhibition of endothelium-derived nitric oxide synthesis causes coronary microvascular...." Circulation. 92. 2636-2644 (1995)
Ito A.等人:“内皮源性一氧化氮合成的长期抑制会导致冠状动脉微血管......”循环。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Takemoto M et al: "Important role of tissue angiotensin-converting enzyme activity in the pathoenesis of coronary vascular..." Journal of Clinical Investigation. 99. 278-287 (1977)
Takemoto M 等人:“组织血管紧张素转换酶活性在冠状血管发病机制中的重要作用......”临床研究杂志。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Numaguchi K.et al.: "Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats" Hypertension. 26part 1. 957-962 (1995)
Numaguchi K.等人:“一氧化氮合成的长期抑制导致大鼠冠状动脉微血管重塑”高血压。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
TAKESHITA Akira其他文献
TAKESHITA Akira的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('TAKESHITA Akira', 18)}}的其他基金
Effect of oral streptococci on the invasion ability of periodontopathic bacterium.
口腔链球菌对牙周病菌侵袭能力的影响
- 批准号:
23593100 - 财政年份:2011
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Effects of Environmental Chemicals on Bone Metabolism through Steroid and Xenobiotic Receptor (SXR)
环境化学物质通过类固醇和异生素受体 (SXR) 对骨代谢的影响
- 批准号:
22591020 - 财政年份:2010
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of virulent mechanism of periodontal pathogen that invades in the mucosal epithelium cells and of effect of antibiotics on the invaded bacterium.
牙周病原菌侵入粘膜上皮细胞的毒力机制及抗生素对侵入细菌的作用分析。
- 批准号:
20592466 - 财政年份:2008
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Periodontal disease pathogenic bacterium Porphyromonas gingivalis invasion is able to induce the expression of inflammatory cytokines.
牙周病致病菌牙龈卟啉单胞菌的入侵能够诱导炎症细胞因子的表达。
- 批准号:
14571748 - 财政年份:2002
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Dominant negative action of SXR AF-2 mutant for multidrug-resistant cancer gene therapy.
SXR AF-2 突变体对多重耐药癌症基因治疗的显着负面作用。
- 批准号:
14571079 - 财政年份:2002
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
MOLECULAR MECHANISMS OF CARDIOVASCULAR REMODELING INDUCED BY CHRONIC INHIBITION OF NITRIC OXIDE SYNTHESIS : ROLE OF NF-κB AND MCP-1
长期抑制一氧化氮合成诱导心血管重塑的分子机制:NF-κB 和 MCP-1 的作用
- 批准号:
10307019 - 财政年份:1998
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (A).
Development of intracellular therapy to induce a regression of coronary arteriosclerotic lesions
开发诱导冠状动脉硬化病变消退的细胞内疗法
- 批准号:
10357006 - 财政年份:1998
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (A).
Physiological and pathophysiological roles of endothelium-derived hyperpotarizing factor in the control of organ perfusion.
内皮衍生的高钾因子在器官灌注控制中的生理和病理生理作用。
- 批准号:
07307010 - 财政年份:1995
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
ROLE OF MICROVASCULAR DISORDERS IN THE PATHOGENESIS OF MYOCARDIAL ISCHEMIA
微血管疾病在心肌缺血发病机制中的作用
- 批准号:
06404034 - 财政年份:1994
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (A)
Role of central GABA system in hypertension induced by high salt and stress.
中枢GABA系统在高盐和应激诱发的高血压中的作用。
- 批准号:
03454256 - 财政年份:1991
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
Structure and function study of angiotensin converting enzyme 2 (ACE2) activating peptides from food proteins
食品蛋白中血管紧张素转换酶 2 (ACE2) 激活肽的结构和功能研究
- 批准号:
RGPIN-2018-04680 - 财政年份:2022
- 资助金额:
$ 8.58万 - 项目类别:
Discovery Grants Program - Individual
Domain-specific inhibition of angiotensin-converting enzyme as a therapeutic strategy for opioid use disorders
血管紧张素转换酶的域特异性抑制作为阿片类药物使用障碍的治疗策略
- 批准号:
10512191 - 财政年份:2022
- 资助金额:
$ 8.58万 - 项目类别:
Role of gut commensal Coprococcus comes in angiotensin-converting enzyme inhibitor resistant hypertension
肠道共生粪球菌在血管紧张素转换酶抑制剂抵抗性高血压中的作用
- 批准号:
10509954 - 财政年份:2022
- 资助金额:
$ 8.58万 - 项目类别:
Role of gut commensal Coprococcus comes in angiotensin-converting enzyme inhibitor resistant hypertension
肠道共生粪球菌在血管紧张素转换酶抑制剂抵抗性高血压中的作用
- 批准号:
10676297 - 财政年份:2022
- 资助金额:
$ 8.58万 - 项目类别:
Functional analysis of angiotensin-converting enzyme 2 in the brain and development of novel therapeutic agents for depression
脑血管紧张素转换酶2的功能分析及新型抑郁症治疗药物的开发
- 批准号:
22K06866 - 财政年份:2022
- 资助金额:
$ 8.58万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
COVID-19 Variant Supplement - Molecular and cellular therapies against COVID-19 using angiotensin-converting enzyme 2 (ACE2)
COVID-19 变异补充剂 - 使用血管紧张素转换酶 2 (ACE2) 对抗 COVID-19 的分子和细胞疗法
- 批准号:
443128 - 财政年份:2021
- 资助金额:
$ 8.58万 - 项目类别:
Operating Grants
Determine how the interaction between SARS-CoV-2 spike protein and angiotensin-converting enzyme 2 (ACE2) affect viral spread and the severity of COVID-19 outcomes.
确定 SARS-CoV-2 刺突蛋白和血管紧张素转换酶 2 (ACE2) 之间的相互作用如何影响病毒传播和 COVID-19 结果的严重程度。
- 批准号:
449017 - 财政年份:2021
- 资助金额:
$ 8.58万 - 项目类别:
Operating Grants
Development and Evaluation of Radiotracers for PET Imaging Angiotensin-Converting Enzyme 2 (ACE2)
PET 成像血管紧张素转换酶 2 (ACE2) 放射性示踪剂的开发和评估
- 批准号:
10286888 - 财政年份:2021
- 资助金额:
$ 8.58万 - 项目类别:
Development and Evaluation of Radiotracers for PET Imaging Angiotensin-Converting Enzyme 2 (ACE2)
PET 成像血管紧张素转换酶 2 (ACE2) 放射性示踪剂的开发和评估
- 批准号:
10612920 - 财政年份:2021
- 资助金额:
$ 8.58万 - 项目类别:
Interaction between genetic, lifestyle and environmental factors determining circulating angiotensin-converting enzyme 2 protein expression: implications for the severity of COVID-19 infection
遗传、生活方式和环境因素之间的相互作用决定循环血管紧张素转换酶 2 蛋白表达:对 COVID-19 感染严重程度的影响
- 批准号:
10228516 - 财政年份:2021
- 资助金额:
$ 8.58万 - 项目类别:














{{item.name}}会员




